Exploring the Incorporation of a Novel Cardiotoxicity Mobile Health App Into Care of Patients With Cancer: Qualitative Study of Patient and Provider Perspectives.

Autor:	Gregory ME; Department of Health Outcomes and Biomedical Informatics, College of Medicine, Univeristy of Florida, Gainesville, FL, United States., Cao W; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Rahurkar S; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.; The Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), College of Medicine, The Ohio State University, Columbus, OH, United States., Jonnalagadda P; The Center for the Advancement of Team Science, Analytics, and Systems Thinking (CATALYST), College of Medicine, The Ohio State University, Columbus, OH, United States., Stock JC; Cardio-Oncology Program, Division of Cardiovascular Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Ghazi SM; Cardio-Oncology Program, Division of Cardiovascular Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States., Reid E; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Berk AL; Biomedical Sciences Program, College of Medicine, The Ohio State University, Columbus, OH, United States., Hebert C; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Li L; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States., Addison D; Cardio-Oncology Program, Division of Cardiovascular Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.
Jazyk:	angličtina
Zdroj:	JMIR cancer [JMIR Cancer] 2023 Dec 12; Vol. 9, pp. e46481. Date of Electronic Publication: 2023 Dec 12.
DOI:	10.2196/46481
Abstrakt:	Background: Cardiotoxicity is a limitation of several cancer therapies and early recognition improves outcomes. Symptom-tracking mobile health (mHealth) apps are feasible and beneficial, but key elements for mHealth symptom-tracking to indicate early signs of cardiotoxicity are unknown. Objective: We explored considerations for the design of, and implementation into a large academic medical center, an mHealth symptom-tracking tool for early recognition of cardiotoxicity in patients with cancer after cancer therapy initiation. Methods: We conducted semistructured interviews of >50% of the providers (oncologists, cardio-oncologists, and radiation oncologists) who manage cancer treatment-related cardiotoxicity in the participating institution (n=11), and either interviews or co-design or both with 6 patients. Data were coded and analyzed using thematic analysis. Results: Providers indicated that there was no existing process to enable early recognition of cardiotoxicity and felt the app could reduce delays in diagnosis and lead to better patient outcomes. Signs and symptoms providers recommended for tracking included chest pain or tightness, shortness of breath, heart racing or palpitations, syncope, lightheadedness, edema, and excessive fatigue. Implementation barriers included determining who would receive symptom reports, ensuring all members of the patient's care team (eg, oncologist, cardiologist, and primary care) were informed of the symptom reports and could collaborate on care plans, and how to best integrate the app data into the electronic health record. Patients (n=6, 100%) agreed that the app would be useful for enhanced symptom capture and education and indicated willingness to use it. Conclusions: Providers and patients agree that a patient-facing, cancer treatment-related cardiotoxicity symptom-tracking mHealth app would be beneficial. Additional studies evaluating the role of mHealth as a potential strategy for targeted early cardioprotective therapy initiation are needed. (©Megan E Gregory, Weidan Cao, Saurabh Rahurkar, Pallavi Jonnalagadda, James C Stock, Sanam M Ghazi, Endia Reid, Abigail L Berk, Courtney Hebert, Lang Li, Daniel Addison. Originally published in JMIR Cancer (https://cancer.jmir.org), 12.12.2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu